trial · primary record
filgrastim
Multiple Myeloma and Plasma Cell Neoplasm
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 77 |
| Primary completion | 2018-01-09 |
| Primary endpoint | Best Response Prior to Tandem Autologous Stem Cell Transplant |
| Registry ID | NCT00004088 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:05.957Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT00004088
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Filgrastim · approval
- filgrastim · compound